News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
ACROBiosystems Enhances Custom GMP Grade Protein Services with Expanded Offerings
Thursday, June 08, 2023ACROBiosystems is a reputable company in the field of cell and gene therapy CGT providing a comprehensive range of services to support the commercialization of these advanced therapies CGT involves enhancing the immune system to combat cancer by infu...
Single Cell Discoveries Procures Illumina NovaSeq X Plus, Making History in the Benelux Region
Thursday, June 08, 2023Single Cell Discoveries a Contract Research Organization CRO specializing in singlecell sequencing has proudly announced the introduction of the Illumina NovaSeq X Plus sequencing system in the Benelux region This marks a significant achievement for...
Emergex Announces Encouraging Phase I Trial Findings for DengueTcP™, an Innovative T Cell-Priming Immune Set-Point Candidate
Wednesday, June 07, 2023Emergex Vaccines Holding Limited a clinicalstage biotechnology company has reported positive outcomes from its initial clinical trial of DengueTcP a candidate aimed at combatting the Dengue virus and Dengue Fever
Amphera's MesoPher Receives Positive Opinion from European Medicines Agency for Orphan Medicinal Product Designation in Pancreatic Cancer
Wednesday, June 07, 2023Amphera BV a biotechnology company in the late stages of development has made an announcement regarding its cell therapy called MesoPher The Committee for Orphan Medicinal Products COMP of the European Medicines Agency EMA has recommended granting or...
Domain Therapeutics unveils DT-9045, a groundbreaking PAR2 NAM candidate, for potential advancements in cancer treatment
Tuesday, June 06, 2023Domain Therapeutics a clinicalstage biopharmaceutical company focused on immunooncology drugs that target G ProteinCoupled Receptors GPCRs has announced the selection of its latest drug candidate DT This candidate is a Negative Allosteric Modulator N...
ANeuroTech's ANT-01, an Adjunctive Anti-Depression Drug, Receives FDA IND Approval for Pivotal Phase IIIB Trial
Tuesday, June 06, 2023ANeuroTech a pioneering company in the field of mental health treatments with minimal or no side effects has received approval from the US Food and Drug Administration FDA to begin a pivotal Phase IIIB trial of their drug ANT This trial will investig...
VaxEquity and CPI Secure Innovate UK Grant to Accelerate Advancements in Next-Generation RNA Vaccines and Therapeutics
Monday, June 05, 2023VaxEquity and CPI have received a grant of approximately K from Innovate UK to collaborate on a project focused on enhancing the manufacturing process for RNA vaccines and therapeutics Their goal is to optimize the scalability of selfamplifying RNA s...
BioNTech and OncoC4 Present Promising Phase 1/2 Findings for BNT316/ONC-392 Antibody Candidate in Hard-to-Treat NSCLC at ASCO
Saturday, June 03, 2023BioNTech SE Nasdaq BNTX and OncoC Inc recently released positive preliminary data from their Phase trial involving BNTONC an antiCTLA antibody candidate for the treatment of metastatic PDLresistant nonsmall cell lung cancer NSCLC
Astrea Bioseparations joins Biotage, enabling groundbreaking chromatography solutions
Friday, June 02, 2023Biotage has completed the acquisition of Astrea Bioseparations a highgrowth chromatography solutions provider from Gamma Biosciences a life sciences tools platform created by KKR
REALM IDx Introduces REALM Pharma Services to Enhance Drug Development and Research
Friday, June 02, 2023REALM IDx made an announcement today regarding the introduction of REALM Pharma Services This new service aims to provide a complete solution for biotechnology and pharmaceutical partners covering discovery translational research and clinical trial s...
